Stock Information
Incyte Corp (INCY)
Ticker Symbol: INCY
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $20,160.38 mil
Piotroski score: 8
PE Ratio: 16.9617
EPS (TTM): 5.9146
Revenue (TTM): $23.89 M
Dividend Yield: N/A%
ROE: 29.83%
Latest News
-
Incyte (INCY): Revisiting Valuation After a Strong Year-to-Date Share Price Rally
Thu, Dec 18, 2025 10:12 PM
-
EC Approves Label Expansion of INCY's Lymphoma Drug Minjuvi
Thu, Dec 18, 2025 2:30 PM
-
Incyte to Present at Upcoming Investor Conference
Thu, Dec 18, 2025 1:00 PM
-
Best Defensive Stocks To Balance Tech Sector Volatility
Thu, Dec 18, 2025 8:30 AM
-
Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma
Wed, Dec 17, 2025 4:20 PM
-
Tracking Baker Brothers Portfolio - Q3 2025 Update
Tue, Dec 16, 2025 9:19 AM
-
Is Incyte Stock Outperforming the Nasdaq?
Mon, Dec 15, 2025 1:21 PM
-
Healthcare Dashboard For December And Focus On PJP
Sun, Dec 14, 2025 2:00 PM
Key Financials
Financial data not available
